Artigos de revistas sobre o tema "Kallikrein-Related peptidase 5"
Crie uma referência precisa em APA, MLA, Chicago, Harvard, e outros estilos
Veja os 50 melhores artigos de revistas para estudos sobre o assunto "Kallikrein-Related peptidase 5".
Ao lado de cada fonte na lista de referências, há um botão "Adicionar à bibliografia". Clique e geraremos automaticamente a citação bibliográfica do trabalho escolhido no estilo de citação de que você precisa: APA, MLA, Harvard, Chicago, Vancouver, etc.
Você também pode baixar o texto completo da publicação científica em formato .pdf e ler o resumo do trabalho online se estiver presente nos metadados.
Veja os artigos de revistas das mais diversas áreas científicas e compile uma bibliografia correta.
Ismail, Maha Imam Ahmed, *. Manal Basyouni Ahmed * Manal Basyouni Ahmed e Muneera Al-Sheeha. "Evaluation of kallikrein-related peptidase 5 [KLK5] and Survivin as Prognostic Markers in Breast Cancer". International Journal of Scientific Research 3, n.º 5 (1 de junho de 2012): 398–401. http://dx.doi.org/10.15373/22778179/may2014/124.
Texto completo da fonteZingkou, Eleni, Georgios Pampalakis e Georgia Sotiropoulou. "Exacerbated dandruff in the absence of kallikrein‐related peptidase 5 protease". Journal of Dermatology 47, n.º 3 (7 de janeiro de 2020): 311–13. http://dx.doi.org/10.1111/1346-8138.15174.
Texto completo da fonteSidiropoulos, Konstantinos G., Nicole M. A. White, Anna Bui, Qiang Ding, Peter Boulos, Georgios Pampalakis, Heba Khella, Joseph N. Samuel, Georgia Sotiropoulou e George M. Yousef. "Kallikrein-related peptidase 5 induces miRNA-mediated anti-oncogenic pathways in breast cancer". Oncoscience 1, n.º 11 (24 de outubro de 2014): 709–24. http://dx.doi.org/10.18632/oncoscience.91.
Texto completo da fonteMalachias, Apostolos, Georgia Papachristopoulou, Dimitrios Kypraios, Stefanos P. Bassioukas, Maria Nikaki, Dimitrios Xinopoulos e Maroulio Talieri. "Sa1973 Analysis and Clinical Evaluation of Kallikrein-Related Peptidase 5 (KLK5) in Colon Cancer". Gastroenterology 148, n.º 4 (abril de 2015): S—372. http://dx.doi.org/10.1016/s0016-5085(15)31246-4.
Texto completo da fonteOrtloff, A., F. A. Bustamante, L. Molina, J. Ojeda, C. D. Figueroa e P. Ehrenfeld. "Kallikrein-related Peptidase 5 (KLK5) Expression and Distribution in Canine Cutaneous Squamous Cell Carcinoma". Journal of Comparative Pathology 174 (janeiro de 2020): 113–19. http://dx.doi.org/10.1016/j.jcpa.2019.11.009.
Texto completo da fonteSakabe, Jun-ichi, Mami Yamamoto, Satoshi Hirakawa, Akira Motoyama, Isao Ohta, Kazuki Tatsuno, Taisuke Ito, Kenji Kabashima, Toshihiko Hibino e Yoshiki Tokura. "Kallikrein-related Peptidase 5 Functions in Proteolytic Processing of Profilaggrin in Cultured Human Keratinocytes". Journal of Biological Chemistry 288, n.º 24 (29 de abril de 2013): 17179–89. http://dx.doi.org/10.1074/jbc.m113.476820.
Texto completo da fonteLin, Yongbo, Li Ma, Hanliang Dan, Gang Chen, Jian Dai, Liang Xu e Yuqi Liu. "MiR-107-3p Knockdown Alleviates Endothelial Injury in Sepsis via Kallikrein-Related Peptidase 5". Journal of Surgical Research 292 (dezembro de 2023): 264–74. http://dx.doi.org/10.1016/j.jss.2023.07.013.
Texto completo da fonteYoon, Hyesook, e Isobel A. Scarisbrick. "Kallikrein-related peptidase 6 exacerbates disease in an autoimmune model of multiple sclerosis". Biological Chemistry 397, n.º 12 (1 de dezembro de 2016): 1277–86. http://dx.doi.org/10.1515/hsz-2016-0239.
Texto completo da fonteWu, Yanhua, Yingjian Chen, Qing Li, Yanwen Gong, Xiaohong Liu, Liquan Bi e Chengjin Hu. "Upregulation of kallikrein-related peptidase 5 is associated with the malignant behavior of colorectal cancer". Molecular Medicine Reports 14, n.º 3 (13 de julho de 2016): 2164–70. http://dx.doi.org/10.3892/mmr.2016.5516.
Texto completo da fontePetraki, Constantina, Youssef M. Youssef, William Dubinski, Zsuzsanna Lichner, Andreas Scorilas, Maria D. Pasic, Vassilios Komborozos et al. "Evaluation and prognostic significance of human tissue kallikrein-related peptidase 10 (KLK10) in colorectal cancer". Tumor Biology 33, n.º 4 (22 de março de 2012): 1209–14. http://dx.doi.org/10.1007/s13277-012-0368-5.
Texto completo da fonteMagnen, Mélia, Brigitta Margit Elsässer, Olga Zbodakova, Petr Kasparek, Fabien Gueugnon, Agnès Petit-Courty, Radislav Sedlacek, Peter Goettig e Yves Courty. "Kallikrein-related peptidase 5 and seasonal influenza viruses, limitations of the experimental models for activating proteases". Biological Chemistry 399, n.º 9 (25 de setembro de 2018): 1053–64. http://dx.doi.org/10.1515/hsz-2017-0340.
Texto completo da fonteMontenegro, Sara Estefania, Jang-Hee Oh, Joong Heon Suh, Je-Ho Mun e Jin Ho Chung. "Higher Expression of Lympho-epithelial Kazal-type-Related Inhibitor-1 Fragments and Decreased Desquamation in the Lesional Skin of Nummular Eczema". Acta Dermato-Venereologica 104 (29 de março de 2024): adv188636. http://dx.doi.org/10.2340/actadv.v104.18636.
Texto completo da fonteNohara, Kyoko, Kazuhiko Yamada, Leo Yamada, Teruki Hagiwara, Toru Igari, Chizu Yokoi, Daisuke Soma, Satoshi Yamashita, Taeko Dohi e Yuki I. Kawamura. "Expression of kallikrein-related peptidase 13 is associated with poor prognosis in esophageal squamous cell carcinoma". General Thoracic and Cardiovascular Surgery 66, n.º 6 (26 de março de 2018): 351–57. http://dx.doi.org/10.1007/s11748-018-0910-5.
Texto completo da fonteLee, Chia-Yao, David Marzan, Grace Lin, Steve Goodison e Steve Silletti. "α2 Integrin-Dependent Suppression of Pancreatic Adenocarcinoma Cell Invasion Involves Ectodomain Regulation of Kallikrein-Related Peptidase-5". Journal of Oncology 2011 (2011): 1–15. http://dx.doi.org/10.1155/2011/365651.
Texto completo da fontede Veer, Simon J., Joakim E. Swedberg, Maria Brattsand, Judith A. Clements e Jonathan M. Harris. "Exploring the active site binding specificity of kallikrein-related peptidase 5 (KLK5) guides the design of new peptide substrates and inhibitors". Biological Chemistry 397, n.º 12 (1 de dezembro de 2016): 1237–49. http://dx.doi.org/10.1515/hsz-2016-0112.
Texto completo da fontePapachristopoulou, Georgia, Apostolos Malachias, Marina Devetzi, Evdoxia Kamouza, Andreas Scorilas, Dimitris Xynopoulos e Maroulio Talieri. "Uncovering the clinical impact of kallikrein-related peptidase 5 (KLK5) mRNA expression in the colorectal adenoma-carcinoma sequence". Clinical Chemistry and Laboratory Medicine (CCLM) 57, n.º 8 (26 de julho de 2019): 1251–60. http://dx.doi.org/10.1515/cclm-2018-1010.
Texto completo da fonteBandiera, Elisabetta, Laura Zanotti, Eliana Bignotti, Chiara Romani, Renata Tassi, Paola Todeschini, Germana Tognon et al. "Human Kallikrein 5: An Interesting Novel Biomarker in Ovarian Cancer Patients That Elicits Humoral Response". International Journal of Gynecologic Cancer 19, n.º 6 (julho de 2009): 1015–21. http://dx.doi.org/10.1111/igc.0b013e3181ab597f.
Texto completo da fontePampalakis, Georgios, Eleni Zingkou e Georgia Sotiropoulou. "KLK5, a novel potential suppressor of vaginal carcinogenesis". Biological Chemistry 399, n.º 9 (25 de setembro de 2018): 1107–11. http://dx.doi.org/10.1515/hsz-2017-0302.
Texto completo da fonteFurio, Laetitia, Simon de Veer, Madeleine Jaillet, Anais Briot, Aurelie Robin, Celine Deraison e Alain Hovnanian. "Transgenic kallikrein 5 mice reproduce major cutaneous and systemic hallmarks of Netherton syndrome". Journal of Experimental Medicine 211, n.º 3 (17 de fevereiro de 2014): 499–513. http://dx.doi.org/10.1084/jem.20131797.
Texto completo da fonteWu, Yanhua, Xiaofei Liu, Yingjian Chen e Chengjin Hu. "Development and evaluation of an ELISA method for the measurement of kallikrein-related peptidase 5 (KLK5) in human serum". Open Journal of Clinical Diagnostics 03, n.º 04 (2013): 159–66. http://dx.doi.org/10.4236/ojcd.2013.34029.
Texto completo da fonteMeyer-Hoffert, Ulf, Zhihong Wu e Jens-Michael Schröder. "Identification of Lympho-Epithelial Kazal-Type Inhibitor 2 in Human Skin as a Kallikrein-Related Peptidase 5-Specific Protease Inhibitor". PLoS ONE 4, n.º 2 (3 de fevereiro de 2009): e4372. http://dx.doi.org/10.1371/journal.pone.0004372.
Texto completo da fontePlanque, Chris, Yun-Hee Choi, Serge Guyetant, Nathalie Heuzé-Vourc'h, Laurent Briollais e Yves Courty. "Alternative Splicing Variant of Kallikrein-Related Peptidase 8 as an Independent Predictor of Unfavorable Prognosis in Lung Cancer". Clinical Chemistry 56, n.º 6 (1 de junho de 2010): 987–97. http://dx.doi.org/10.1373/clinchem.2009.138917.
Texto completo da fonteReid, Janet C., Nigel C. Bennett, Carson R. Stephens, Melanie L. Carroll, Viktor Magdolen, Judith A. Clements e John D. Hooper. "In vitro evidence that KLK14 regulates the components of the HGF/Met axis, pro-HGF and HGF-activator inhibitor 1A and 1B". Biological Chemistry 397, n.º 12 (1 de dezembro de 2016): 1299–305. http://dx.doi.org/10.1515/hsz-2016-0163.
Texto completo da fonteAvgeris, Margaritis, Georgia Papachristopoulou, Athanasios Polychronis e Andreas Scorilas. "Down-regulation of kallikrein-related peptidase 5 (KLK5) expression in breast cancer patients: a biomarker for the differential diagnosis of breast lesions". Clinical Proteomics 8, n.º 1 (2011): 5. http://dx.doi.org/10.1186/1559-0275-8-5.
Texto completo da fonteWeidinger, Stephan, Hansjörg Baurecht, Stefan Wagenpfeil, John Henderson, Natalija Novak, Aileen Sandilands, Huijia Chen et al. "Analysis of the individual and aggregate genetic contributions of previously identified serine peptidase inhibitor Kazal type 5 (SPINK5), kallikrein-related peptidase 7 (KLK7), and filaggrin (FLG) polymorphisms to eczema risk". Journal of Allergy and Clinical Immunology 122, n.º 3 (setembro de 2008): 560–68. http://dx.doi.org/10.1016/j.jaci.2008.05.050.
Texto completo da fonteBrännström, Kristoffer, Anders Öhman, Ulrich von Pawel Rammingen, Anders Olofsson e Maria Brattsand. "Characterization of SPINK9, a KLK5-specific inhibitor expressed in palmo-plantar epidermis". Biological Chemistry 393, n.º 5 (1 de maio de 2012): 369–77. http://dx.doi.org/10.1515/hsz-2011-0238.
Texto completo da fonteFukushima, Tsuyoshi, Shuichiro Uchiyama, Hiroyuki Tanaka e Hiroaki Kataoka. "Hepatocyte Growth Factor Activator: A Proteinase Linking Tissue Injury with Repair". International Journal of Molecular Sciences 19, n.º 11 (1 de novembro de 2018): 3435. http://dx.doi.org/10.3390/ijms19113435.
Texto completo da fonteNomura, Hayato, Mutsumi Suganuma, Takuya Takeichi, Michihiro Kono, Yuki Isokane, Ko Sunagawa, Mina Kobashi et al. "Multifaceted Analyses of Epidermal Serine Protease Activity in Patients with Atopic Dermatitis". International Journal of Molecular Sciences 21, n.º 3 (30 de janeiro de 2020): 913. http://dx.doi.org/10.3390/ijms21030913.
Texto completo da fonteIshida, Koichi, Liyue Qin, Ting Wang, Ying Lei, Weiwei Hu, Geng Zhu, Qianqian Zhuang et al. "Local mechanisms for acupoint sensitization in gall bladder meridian of foot shaoyang-a gene chip study". Acupuncture & Electro-Therapeutics Research 44, n.º 2 (1 de junho de 2019): 77–87. http://dx.doi.org/10.3727/036012919x15650315071898.
Texto completo da fonteSchaap, Mirjam J., Finola M. Bruins, Xuehui He, Kadri Orro, Malou Peppelman, Piet E. J. van Erp, Elke M. G. J. de Jong, Hans J. P. M. Koenen, Ellen H. van den Bogaard e Marieke M. B. Seyger. "Skin Surface Protein Detection by Transdermal Analysis Patches in Pediatric Psoriasis". Skin Pharmacology and Physiology 34, n.º 5 (2021): 271–80. http://dx.doi.org/10.1159/000516110.
Texto completo da fonteBeaufort, Nathalie, Karolina Plaza, Daniel Utzschneider, Amelie Schwarz, Julia M. Burkhart, Sabine Creutzburg, Mekdes Debela, Manfred Schmitt, Christian Ries e Viktor Magdolen. "Interdependence of kallikrein-related peptidases in proteolytic networks". Biological Chemistry 391, n.º 5 (1 de maio de 2010): 581–87. http://dx.doi.org/10.1515/bc.2010.055.
Texto completo da fonteJung, Monika, Annika Schaefer, Isabel Steiner, Carsten Kempkensteffen, Carsten Stephan, Andreas Erbersdobler e Klaus Jung. "Robust MicroRNA Stability in Degraded RNA Preparations from Human Tissue and Cell Samples". Clinical Chemistry 56, n.º 6 (1 de junho de 2010): 998–1006. http://dx.doi.org/10.1373/clinchem.2009.141580.
Texto completo da fontePathak, Monika, Szu Shen Wong, Ingrid Dreveny e Jonas Emsley. "Structure of plasma and tissue kallikreins". Thrombosis and Haemostasis 110, n.º 09 (2013): 423–33. http://dx.doi.org/10.1160/th12-11-0840.
Texto completo da fonteChee, Jessica, Jasmine Singh, Anupam Naran, Neil L. Misso, Philip J. Thompson e Kanti D. Bhoola. "Novel expression of kallikreins, kallikrein-related peptidases and kinin receptors in human pleural mesothelioma". Biological Chemistry 388, n.º 11 (1 de novembro de 2007): 1235–42. http://dx.doi.org/10.1515/bc.2007.139.
Texto completo da fonteSarwar, Md Shahid, Christina N. Ramirez, Hsiao-Chen Dina Kuo, Pochung Chou, Renyi Wu, Davit Sargsyan, Ahmad Shannar et al. "Abstract 5266: Metabolic rewiring and epigenetic reprogramming by the environmental carcinogen benzo[a]pyrene in a two-stage skin carcinogenesis mouse model and cancer interception by triterpenoid ursolic acid". Cancer Research 83, n.º 7_Supplement (4 de abril de 2023): 5266. http://dx.doi.org/10.1158/1538-7445.am2023-5266.
Texto completo da fonteHamilton, Brian S., e Gary R. Whittaker. "Cleavage Activation of Human-adapted Influenza Virus Subtypes by Kallikrein-related Peptidases 5 and 12". Journal of Biological Chemistry 288, n.º 24 (23 de abril de 2013): 17399–407. http://dx.doi.org/10.1074/jbc.m112.440362.
Texto completo da fonteWang, Ping, Viktor Magdolen, Christof Seidl, Julia Dorn, Enken Drecoll, Matthias Kotzsch, Feng Yang et al. "Kallikrein-related peptidases 4, 5, 6 and 7 regulate tumour-associated factors in serous ovarian cancer". British Journal of Cancer 119, n.º 7 (outubro de 2018): 1–9. http://dx.doi.org/10.1038/s41416-018-0260-1.
Texto completo da fonteKeuylian, Zela, e Alain Hovnanian. "Mechanistic insight from murine models of Netherton syndrome". Biological Chemistry 397, n.º 12 (1 de dezembro de 2016): 1223–28. http://dx.doi.org/10.1515/hsz-2016-0203.
Texto completo da fonteOlkhov, E., T. H. Van Der Kwast, K. Kron, V. Pethe, H. Ozcelik, L. Briollais, N. E. Fleshner, E. P. Diamandis, A. R. Zlotta e B. Bapat. "543 Methylation of Kallikrein-related peptidases as novel diagnostic and prognostic biomarkers for prostate cancer". European Urology Supplements 11, n.º 1 (fevereiro de 2012): e543-e543a. http://dx.doi.org/10.1016/s1569-9056(12)60540-5.
Texto completo da fonteEhrenfeld, Pamela, Carlos D. Figueroa, Luis Molina, Tania Koning, Myriam Velasco, Felipe A. Bustamante-Barrientos e Alexander Ortloff. "Expression and Distribution of Kallikrein-related Peptidases 5, 7, 8 and 10 in Normal Apocrine Gland of Canine Skin". International Journal of Morphology 41, n.º 1 (fevereiro de 2023): 210–15. http://dx.doi.org/10.4067/s0717-95022023000100210.
Texto completo da fonteShahinian, Hasmik, Daniela Loessner, Martin L. Biniossek, Jayachandran N. Kizhakkedathu, Judith A. Clements, Viktor Magdolen e Oliver Schilling. "Secretome and degradome profiling shows that Kallikrein-related peptidases 4, 5, 6, and 7 induce TGFβ-1 signaling in ovarian cancer cells". Molecular Oncology 8, n.º 1 (1 de outubro de 2013): 68–82. http://dx.doi.org/10.1016/j.molonc.2013.09.003.
Texto completo da fonteJendrny, Cathleen, e Annette G. Beck-Sickinger. "Inhibition of Kallikrein-Related Peptidases 7 and 5 by Grafting Serpin Reactive-Center Loop Sequences onto Sunflower Trypsin Inhibitor-1 (SFTI-1)". ChemBioChem 17, n.º 8 (22 de dezembro de 2015): 719–26. http://dx.doi.org/10.1002/cbic.201500539.
Texto completo da fonteBarabe, J., D. Huberdeau e A. Bernoussi. "Influence of sodium balance on urinary excretion of immunoreactive kinins in rats". American Journal of Physiology-Renal Physiology 254, n.º 4 (1 de abril de 1988): F484—F491. http://dx.doi.org/10.1152/ajprenal.1988.254.4.f484.
Texto completo da fonteThomadaki, Hellinida, Konstantinos Mavridis, Maroulio Talieri e Andreas Scorilas. "Treatment of PC3 prostate cancer cells with mitoxantrone, etoposide, doxorubicin and carboplatin induces distinct alterations in the expression of kallikreins 5 and 11". Thrombosis and Haemostasis 101, n.º 02 (2009): 373–80. http://dx.doi.org/10.1160/th08-01-0025.
Texto completo da fonteJendrny, Cathleen, e Annette G. Beck-Sickinger. "Inside Back Cover: Inhibition of Kallikrein-Related Peptidases 7 and 5 by Grafting Serpin Reactive-Center Loop Sequences onto Sunflower Trypsin Inhibitor-1 (SFTI-1) (ChemBioChem 8/2016)". ChemBioChem 17, n.º 8 (5 de abril de 2016): 784. http://dx.doi.org/10.1002/cbic.201600146.
Texto completo da fonteChavakis, Triantafyllos, Sandip M. Kanse, Florea Lupu, Hans-Peter Hammes, Werner Müller-Esterl, Robin A. Pixley, Robert W. Colman e Klaus T. Preissner. "Different mechanisms define the antiadhesive function of high molecular weight kininogen in integrin- and urokinase receptor–dependent interactions". Blood 96, n.º 2 (15 de julho de 2000): 514–22. http://dx.doi.org/10.1182/blood.v96.2.514.
Texto completo da fonteChavakis, Triantafyllos, Sandip M. Kanse, Florea Lupu, Hans-Peter Hammes, Werner Müller-Esterl, Robin A. Pixley, Robert W. Colman e Klaus T. Preissner. "Different mechanisms define the antiadhesive function of high molecular weight kininogen in integrin- and urokinase receptor–dependent interactions". Blood 96, n.º 2 (15 de julho de 2000): 514–22. http://dx.doi.org/10.1182/blood.v96.2.514.014k45_514_522.
Texto completo da fonteLuo, Yanmin, Premlata Kumar e Carole R. Mendelson. "Estrogen-Related Receptor γ (ERRγ) Regulates Oxygen-Dependent Expression of Voltage-gated Potassium (K+) Channels and Tissue Kallikrein during Human Trophoblast Differentiation". Molecular Endocrinology 27, n.º 6 (1 de junho de 2013): 940–52. http://dx.doi.org/10.1210/me.2013-1038.
Texto completo da fonteBandiera, Elisabetta, Laura Zanotti, Eliana Bignotti, Chiara Romani, Renata Tassi, Paola Todeschini, Germana Tognon et al. "Human Kallikrein 5: An Interesting Novel Biomarker in Ovarian Cancer Patients that Elicits a Humoral Response". International Journal of Biological Markers 24, n.º 3 (julho de 2009): 211. http://dx.doi.org/10.1177/172460080902400337.
Texto completo da fonteDong, Y., L. T. Bui, D. M. Odorico, O. L. Tan, S. A. Myers, H. Samaratunga, R. A. Gardiner e J. A. Clements. "Compartmentalized expression of kallikrein 4 (KLK4/hK4) isoforms in prostate cancer: nuclear, cytoplasmic and secreted forms". Endocrine-Related Cancer 12, n.º 4 (dezembro de 2005): 875–89. http://dx.doi.org/10.1677/erc.1.01062.
Texto completo da fonte